| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Autoantibodies targeting TLR and SMAD pathways define new subgroups in systemic lupus erythematosus
|
Lewis, Myles J.
|
|
2018
|
91 |
C |
p. 1-12
|
artikel
|
| 2 |
Characterization of Blimp-1 function in effector regulatory T cells
|
Cretney, Erika
|
|
2018
|
91 |
C |
p. 73-82
|
artikel
|
| 3 |
Editorial Board
|
|
|
2018
|
91 |
C |
p. ii
|
artikel
|
| 4 |
Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients
|
Mekinian, Arsene
|
|
2018
|
91 |
C |
p. 55-60
|
artikel
|
| 5 |
Gain of function mutation and inflammasome driven diseases in human and mouse models
|
Cordero, Mario D.
|
|
2018
|
91 |
C |
p. 13-22
|
artikel
|
| 6 |
iNKT cells ameliorate human autoimmunity: Lessons from alopecia areata
|
Ghraieb, Amal
|
|
2018
|
91 |
C |
p. 61-72
|
artikel
|
| 7 |
Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in mice
|
Hintermann, Edith
|
|
2018
|
91 |
C |
p. 83-96
|
artikel
|
| 8 |
Mechanisms of neuropsychiatric lupus: The relative roles of the blood-cerebrospinal fluid barrier versus blood-brain barrier
|
Gelb, Sivan
|
|
2018
|
91 |
C |
p. 34-44
|
artikel
|
| 9 |
Systemic activation of NLRP3 inflammasome in patients with severe primary Sjögren's syndrome fueled by inflammagenic DNA accumulations
|
Vakrakou, Aigli G.
|
|
2018
|
91 |
C |
p. 23-33
|
artikel
|
| 10 |
TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis
|
Bodewes, Iris L.A.
|
|
2018
|
91 |
C |
p. 97-102
|
artikel
|
| 11 |
The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus
|
Kraaij, Tineke
|
|
2018
|
91 |
C |
p. 45-54
|
artikel
|
Tijdschrift beschrijving